CN1657078A - Medicine for treating mastosis - Google Patents

Medicine for treating mastosis Download PDF

Info

Publication number
CN1657078A
CN1657078A CN 200410025882 CN200410025882A CN1657078A CN 1657078 A CN1657078 A CN 1657078A CN 200410025882 CN200410025882 CN 200410025882 CN 200410025882 A CN200410025882 A CN 200410025882A CN 1657078 A CN1657078 A CN 1657078A
Authority
CN
China
Prior art keywords
medicine
present
mastopathy
cyclomastopathy
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410025882
Other languages
Chinese (zh)
Inventor
王永清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410025882 priority Critical patent/CN1657078A/en
Publication of CN1657078A publication Critical patent/CN1657078A/en
Pending legal-status Critical Current

Links

Abstract

A medicine for treating mastoplasia and fibrous mastadenoma is prepared from silazinone, menthol, and 6 Chinese-medicinal materials including trichosanthes fruit, frankincense, myrrh, Chuan-xiong rhizome, etc.

Description

A kind of medicine for the treatment of mastopathy
One, technical field
The present invention relates to a kind of medicine for the treatment of mastopathy, especially a kind of film magnetic breast disease health that is used for benign proliferative diseases treatments such as cyclomastopathy, mammary gland fibroadenoma.
Two, background technology
Cyclomastopathy is meant because of forming a kind of disease due to the cyst after mammary gland glandular tube and the acinus hypertrophy.A kind of mastopathy that right and wrong are usually seen accounts for the first place of mastopathy morbidity.5% cyclomastopathy patient is arranged approximately, and its focus may development and change become breast carcinoma.Mammary gland fibroadenoma is the modal benign tumor of female breast, and it is formed by mammary gland glandular tissue and proliferation of fibrous tissue.Can there be only a few to cancerate.Adopt aspirin to alleviate the pain of disease of hyperplasia of mammary glands glands at present, alleviate its distending pain, alleviate its symptom, can not solve the technical problem of disease of hyperplasia of mammary glands glands from the cause of disease with bromocriptine, danazol etc. with diuretic.
Three, summary of the invention
The medicine that the invention solves the treatment mastopathy in the background technology can't be treated the technical problem of cyclomastopathy, mammary gland fibroadenoma from the cause of disease, and the present invention simultaneously prevents cyclomastopathy, mammary gland fibroadenoma to cancerate to be the effect of breast carcinoma in addition.
Technical solution of the present invention is: the present invention is a kind of medicine for the treatment of mastopathy, and its special character is: the percentage by weight of this medicine consists of Fructus Trichosanthis 26~45%, Olibanum 12~21%, Myrrha 12~21%, Spica Prunellae 12~21%, Rhizoma Cyperi 6~11% and Rhizoma Chuanxiong 6~11%.
Said medicine also comprises azone 0.6~1.0% and Mentholum 0.6~1.0%.
The present invention has following advantage:
1, the present invention not only has significant analgesic activity to the pain of cyclomastopathy, solves symptom problems such as pain, the more important thing is from the cause of disease and treats cyclomastopathy, mammary gland fibroadenoma; The present invention simultaneously prevents cyclomastopathy, mammary gland fibroadenoma to cancerate to be the effect of breast carcinoma in addition.
2, have no side effect after the present invention uses, safe and effective.
Four, the specific embodiment
Percentage by weight of the present invention consists of Fructus Trichosanthis 26~45%, Olibanum 12~21%, Myrrha 12~21%, Spica Prunellae 12~21%, Rhizoma Cyperi 6~11%, Rhizoma Chuanxiong 6~11%, azone 0.6~1.0% and Mentholum 0.6~1.0%.
Regulate estrogen secretion and drain pin, be the main cause that forms disease of hyperplasia of mammary glands glands unusually to estrogen metabolism, therefore the present invention is directed to the cause of disease, performance potentiation is filmed and is drawn together promoting the circulation of QI the chest stuffiness relieving, the eliminating stagnation of withering in the pad; Olibanum, Myrrha and Spica Prunellae are invigorated blood circulation, dissipating blood stasis, clear swollen, pain relieving; That Rhizoma Cyperi, Rhizoma Chuanxiong circulation of qi promoting loose is strongly fragrant, transfer effect such as knot, and by the Nd-Fe-B permanent magnetic sheet, meridian point performance, promoting QI circulation for relieving depression, promoting blood circulation and stopping pain, mass dissipating and swelling eliminating, suppress the synthetic of proliferative cell DNA, RNA, reach the purpose of treatment treatment cyclomastopathy and mammary gland fibroadenoma etc.
Production method of the present invention is as follows:
1, with Fructus Trichosanthis, Olibanum, Myrrha, Spica Prunellae, Rhizoma Cyperi, Rhizoma Chuanxiong crushing screening, use ethanol percolation, the collection diafiltration is standby.
2, above-mentioned reserve liquid is added adjuvants such as azone, Mentholum,, stir evenly back packing rapidly with adding with stirring, airtight.
Concrete proportioning example of the present invention is as follows:
Figure A20041002588200051

Claims (2)

1, a kind of medicine for the treatment of mastopathy is characterized in that: the percentage by weight of this medicine consists of Fructus Trichosanthis 26~45%, Olibanum 12~21%, Myrrha 12~21%, Spica Prunellae 12~21%, Rhizoma Cyperi 6~11% and Rhizoma Chuanxiong 6~11%.
2, the medicine of treatment mastopathy according to claim 1 is characterized in that: this medicine also comprises azone 0.6~1.0% and Mentholum 0.6~1.0%.
CN 200410025882 2004-02-20 2004-02-20 Medicine for treating mastosis Pending CN1657078A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410025882 CN1657078A (en) 2004-02-20 2004-02-20 Medicine for treating mastosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410025882 CN1657078A (en) 2004-02-20 2004-02-20 Medicine for treating mastosis

Publications (1)

Publication Number Publication Date
CN1657078A true CN1657078A (en) 2005-08-24

Family

ID=35006908

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410025882 Pending CN1657078A (en) 2004-02-20 2004-02-20 Medicine for treating mastosis

Country Status (1)

Country Link
CN (1) CN1657078A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836310A (en) * 2011-06-24 2012-12-26 杨喜年 Medicine for treating hyperplasia of mammary glands
CN105853873A (en) * 2016-06-13 2016-08-17 郭洪赈 External preparation for treating breast disease and preparation method thereof
CN112618682A (en) * 2021-01-11 2021-04-09 海南医学院 Formula for treating hyperplasia of mammary glands and mammary gland qi-regulating and stagnation-dissipating patch prepared from formula
CN115737739A (en) * 2022-11-29 2023-03-07 广东罗浮山国药股份有限公司 Composition for treating acute mastitis and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836310A (en) * 2011-06-24 2012-12-26 杨喜年 Medicine for treating hyperplasia of mammary glands
CN105853873A (en) * 2016-06-13 2016-08-17 郭洪赈 External preparation for treating breast disease and preparation method thereof
CN112618682A (en) * 2021-01-11 2021-04-09 海南医学院 Formula for treating hyperplasia of mammary glands and mammary gland qi-regulating and stagnation-dissipating patch prepared from formula
CN115737739A (en) * 2022-11-29 2023-03-07 广东罗浮山国药股份有限公司 Composition for treating acute mastitis and preparation method thereof
CN115737739B (en) * 2022-11-29 2024-02-06 广东罗浮山国药股份有限公司 Composition for treating acute mastitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102631513B (en) Medicinal plaster for removing stasis, eliminating stagnation and relieving swelling and preparation method thereof
CN104826016B (en) A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland
CN107137498A (en) Treat traditional Chinese medicine gel of hemorrhoid and preparation method thereof
CN104491661A (en) Traditional Chinese medicine composition used for treating prostatitis or benign prostatic hyperplasia
CN102397444A (en) Nano-grade gynaecological lotion and preparation method thereof
CN1657078A (en) Medicine for treating mastosis
CN103768478B (en) One is treated prostatitic Chinese medicine composition and its production and use
CN106109811A (en) Treatment cyclomastopathy and the Chinese medicine patch of breast tumor
CN102755515B (en) Traditional Chinese medicine decoction for treating hyperplasia of mammary glands
CN101912586B (en) Medicament for treating mammary gland hyperplasia and preparation method thereof
CN101244175A (en) Chinese medicine emplastrum for treating gland hyperplasia
CN103705632A (en) Application of mammary aggregation dispersing tablets in preparation of medicines for treating penis hardening disease
CN103191369B (en) Chinese medicinal composition for treating mammary gland hyperplasia
CN103083387A (en) Congestion-eliminating pain-relieving plaster
CN102552853B (en) Compound Chinese medicine for treating hypogastralgia and dysmenorrhea caused by endometriosis and preparation method thereof
CN102357232B (en) Traditional Chinese medicine for treating breast disease and preparation method thereof
CN102283973B (en) Traditional Chinese medicine plaster for treating benign tumor and reducing weight and preparation method thereof
CN101810687B (en) Medicament for treating hyperplasia of mammary glands and preparation method thereof
CN101301412B (en) Capsules for soothing depression and dissipating binds
CN104127805A (en) Traditional Chinese medicine preparation used for treating hyperplasia of mammary glands, preparation method and application thereof
CN103816329A (en) Traditional Chinese medicine for treating mammitis and hyperplasia of mammary glands
CN103028059B (en) Traditional Chinese medicine composition for treating cholangiocarcinoma
CN102670858B (en) Lotion for treating inflammatory external hemorrhoids
CN101342288A (en) Traditional Chinese medicine plaster for treating lympha, mammary gland tuberculosis and scaly tetter
CN103356926B (en) Traditional Chinese medicine preparation for treating mammary gland hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication